Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Protox reports positive final results from phase I study of PRX-302 for BPH

Jan. 7, 2008

Novel 5-HT2C receptor agonists emerge from Takeda R&D

Dec. 24, 2007

Recent Sumitomo Chemical patents disclose novel therapeutic agents for chronic renal failure

Dec. 21, 2007

ZymoGenetics and Merck Serono initiate phase II/III clinical trial of atacicept

Dec. 17, 2007

BioMarin enters research and option agreement with IGAN for IgA proteases

Dec. 7, 2007

Novel treatments for urological disorders reported in recent Astellas and Mitsubishi Tanabe patents

Dec. 5, 2007

Nymox reports positive results from clinical study of NX-1207

Dec. 3, 2007

Plethora reports positive preliminary results from phase II study of PSD-503

Dec. 3, 2007

Ardana reports positive preliminary results from phase II study of teverelix LA

Nov. 27, 2007

Cytochroma initiates phase I/II clinical trial of CTAP-101 capsules

Nov. 22, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...